Publications

Filtrer les résultats

Themes
Années
Types
Langues
3 résultats Voir en premier : les plus pertinents | les plus récents
    • Médicaments, Statistiques
    • 2015
    • Rapport
    • Anglais

    [Résumé des dernières données sur la consommation d'antibiotiques dans l'européenne]
    Data on the occurrence and spread of antimicrobial resistance in the European countries.

    • Date de parution:
    • Editeur: European Centre for Disease prevention and Control (ECDC)
    • Médicaments, Statistiques
    • 2015
    • rapport
    • Anglais

    [Surveillance de l'antibiorésistance en Europe]
    Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net).
    This report presents antimicrobial resistance data for seven microorganisms of major public health importance: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter species, Streptococcus pneumoniae, Staphylococcus aureus, and Enterococci. For 2014, data were reported by 29 countries and the report also presents trend analyses for the period 2011–2014.

    • Date de parution:
    • Editeur: European Centre for Disease prevention and Control (ECDC)
    • Médicaments, Statistiques
    • 2015
    • rapport
    • Anglais

    [Mise à jour sur la propagation en Europe d’entérobactéries productrices de carbapénèmase - Résumé de l'analyse d'experts mai 2015]
    This ECDC Evidence Brief identifies urgent priorities for action to combat the occurrence and spread of carbapenemase-producing Enterobacteriaceae (CPE) in Europe. It draws on country data reported by 38 European countries to ECDC following the completion of the ‘European Survey on Carbapenemase-Producing Enterobacteriaceae’ (EuSCAPE) project. The EuSCAPE project aimed to improve understanding of the occurrence and spread of CPE and build laboratory capacity for their diagnosis and surveillance. In 2013, ECDC published the results of a pre-EuSCAPE self-assessment by national experts on the spread of CPE and the national capacity for containment of CPE in terms of surveillance, laboratory capacity, reference services and infection control measures [1,2]. Following this self-assessment, EuSCAPE supported a laboratory capacity building workshop, an external quality assessment and the collection and characterisation of CPE isolates in European hospitals. In 2015, a post-EuSCAPE self-assessment [3] was conducted to re-assess the spread of CPE in European countries, as well as improvements in the capacity for containment of CPE in these countries since 2013.

    • Date de parution:
    • Editeur: European Centre for Disease prevention and Control (ECDC)
  • Dernière modification le 12-10-2015